Solitary recurrence of hilar cholangiocarcinoma in a mediastinal lymp node two years after curative resection

World Journal of Gastroenterology

Volumn 13, Issue 15, 2007, Pages 2243-2246

  Ito, Yuichiro ^a   Tajima, Yoshitsugu ^a   Fujita, Fumihiko ^a   Tsutsumi, Ryuji ^a   Kuroki, Tamotsu ^a   Kanematsu, Takashi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Hilar cholangiocarcinoma; Lymp node metastasis; Mediastinum

Indexed keywords

CA 19-9 ANTIGEN; GAMMA GLUTAMYLTRANSFERASE; UFT;

ABDOMINAL DISCOMFORT; ADJUVANT THERAPY; ADULT; ARTICLE; BILE DUCT CARCINOMA; BILIARY TRACT SURGERY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CASE REPORT; CAUTERIZATION; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; LAPAROSCOPIC SURGERY; LAPAROTOMY; LIVER LOBECTOMY; LUNG NODULE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MEDIASTINUM LYMPH NODE; NAUSEA AND VOMITING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; THORACOSCOPY; TREATMENT OUTCOME;

EID: 34249801805     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v13.i15.2243     Document Type: Article

References (12)

1. Tompkins RK, Saunders K, Roslyn JJ, Longmire WP Jr. Changing patterns in diagnosis and management of bile duct cancer. Ann Surg 1990; 211: 614-620; discussion 620-621
2. Schoenthaler R, Phillips TL, Castro J, Efird JT, Better A, Way LW. Carcinoma of the extrahepatic bile ducts. The University of California at San Francisco experience. Ann Surg 1994; 219: 267-274
3. Nakeeb A, Lipsett PA,, Lillemoe KD, Fox-Talbot MK, Coleman J, Cameron JL, Pitt HA. Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma. Am J Surg 1996; 171: 147-152; discussion 152-153
4. Kurosaki I, Hatakeyama K, Tsukada K. Long-term survival of patients with biliary tract cancers with lymph node involvement. J Hepatobiliary Pancreat Surg 1999; 6: 399-404
5. Todoroki T, Kawamoto T, Koike N, Takahashi H, Yoshida S, Kashiwagi H, Takada Y, Otsuka M, Fukao K. Radical resection of hilar bile duct carcinoma and predictors of survival. Br J Surg 2000; 87: 306-313
6. Kitagawa Y, Nagino M, Kamiya J, Uesaka K, Sano T, Yamamoto H, Hayakawa N, Nimura Y. Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg 2001; 233: 385-392
7. Jarnagin WR, Ruo L, Little SA, Klimstra D, D'Angelica M, DeMatteo RP, Wagman R, Blumgart LH, Fong Y. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer 2003; 98: 1689-1700
8. Kayahara M, Nagakawa T, Ueno K, Ohta T, Takeda T, Miyazaki I. Lymphatic flow in carcinoma of the distal bile duct based on a clinicopathologic study. Cancer 1993; 72: 2112-2117
9. Yoshida T, Shibata K, Yokoyama H, Morii Y, Matsumoto T, Sasaki A, Kitano S. Patterns of lymph node metastasis in carcinoma of the distal bile duct. Hepatogastroenterology 1999; 46: 1595-1598
10. Okami J, Dono K, Sakon M, Tsujie M, Hayashi N, Fujiwara Y, Nagano H, Umeshita K, Nakamori S, Monden M. Patterns of regional lymph node involvement in intrahepatic cholangiocarcinoma of the left lobe. J Gastrointest Surg 2003; 7: 850-856
11. Kitazume N, Okudaira M. The hepatic lymph vessels (in Japanese). Kantansui 1995; 30: 447-451
12. Pederson LC, Buchsbaum DJ, Vickers SM, Kancharla SR, Mayo MS, Curiel DT, Stackhouse MA. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo. Cancer Res 1997; 57: 4325-4332